References
1. Niederman MS, Ferranti RD, Zeigler A, Merrill WW, Reynolds HY. 1984.
Respiratory infection complicating long -term tracheostomy. The
implication of persistent gram-negative tracheobronchial colonization.Chest . 85(1):39-44.
2. Toews GB, Hansen EJ, Strieter RM. 1990. Pulmonary host defenses and
oropharyngeal pathogens. The American Journal of Medicine . 88(5,
Supplement 1):S20-S24.
3. Yu H, Mamey MR, Russell CJ. 2017. Factors associated with 30-day
all-cause hospital readmission after tracheotomy in pediatric patients.Int J Pediatr Otorhinolaryngol. 103:137-141.
4. Zhu H, Das P, Roberson DW, Jang J, Skinner ML, Paine M, Yuan J, Berry
J. 2015. Hospitalizations in children with preexisting tracheostomy: A
national perspective. The Laryngoscope . 125(2):462-468.
5. Russell CJ, Mamey MR, Koh JY, Schrager SM, Neely MN, Wu S. 2018.
Length of stay and hospital revisit after bacterial
tracheostomy-associated respiratory tract infection hospitalizations.Hosp Pediatr. 8(2):72-80.
6. Russell CJ, Mack WJ, Schrager SM, Wu S. 2017. Care variations and
outcomes for children hospitalized with bacterial
tracheostomy-associated respiratory infections. Hospital
Pediatrics . 7(1):16-23.
7. Grosse-Onnebrink J, Rudloff J, Kessler C, Werner C, Dougherty GW,
Kerschke L, Kahl BC, Omran H. 2019. Acinetobacter baumannii is a
risk factor for lower respiratory tract infections in children and
adolescents with a tracheostomy. Pediatr Infect Dis J .
38(10):1005-1009.
8. Russell CJ, Simon TD, Mamey MR, Newth CJL, Neely MN. 2017.Pseudomonas aeruginosa and post-tracheotomy bacterial respiratory
tract infection readmissions. Pediatr Pulmonol . 52(9):1212-1218.
9. Sanders CD, Guimbellot JS, Muhlebach MS, Lin F-C, Gilligan P, Esther
CR. 2018. Tracheostomy in children: Epidemiology and clinical outcomes.Pediatric Pulmonology . 53(9):1269-1275.
10. Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske
CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B et al.
2012. Multidrug-resistant, extensively drug-resistant and
pandrug-resistant bacteria: An international expert proposal for interim
standard definitions for acquired resistance. Clinical
Microbiology and Infection . 18(3):268-281.
11. Rusakow LS, Guarin M, Wegner CB, Rice TB, Mischler EH. 1998.
Suspected respiratory tract infection in the tracheostomized child: The
pediatric pulmonologist’s approach. Chest. 113(6):1549-1554.
12. Goldman JL, Newland JG, Price M, Yu D, Lee BR. 2019. Clinical impact
of an antimicrobial stewardship program on high-risk pediatric patients.Infect Control Hosp Epidemiol . 40(9):968-973.
13. CDC. 2019. Centers for Disease Control and Prevention: Antibiotic
resistance threats in the United States, 2019.
https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-report-508.pdf.
14. Murray MT, Beauchemin MP, Neu N, Larson EL. 2019. Prior antibiotic
use and acquisition of multidrug-resistant organisms in hospitalized
children: A systematic review. Infect Control HospEpidemiol . 40(10):1107-1115.
15. Chen G, Xu K, Sun F, Sun Y, Kong Z, Fang B. 2020. Risk factors of
multidrug-resistant bacteria in lower respiratory tract infections: A
systematic review and meta-analysis. Can J Infect Dis Med
Microbiol. 2020:7268519.
16. Nathwani D, Raman G, Sulham K, Gavaghan M, Menon V. 2014. Clinical
and economic consequences of hospital-acquired resistant and
multidrug-resistant Pseudomonas aeruginosa infections: A
systematic review and meta-analysis. Antimicrob Resist Infect
Control . 3(1):32.
17. Kuster SP, Hasse B, Huebner V, Bansal V, Zbinden R, Ruef C,
Ledergerber B, Weber R. 2010. Risks factors for infections with
extended-spectrum beta-lactamase-producing escherichia coli andKlebsiella pneumoniae at a tertiary care university hospital in
switzerland. Infection . 38(1):33-40.
18. McLaren D, Chitakis M, Burns H, Kapur N. 2021. Airway microbiology
in tracheostomized children. Respiratory Care. 66(2):281-285.
19. McCaleb R, Warren RH, Willis D, Maples HD, Bai S, O’Brien CE. 2016.
Description of respiratory microbiology of children with long-term
tracheostomies. Respir Care. 61(4):447-452.
20. Harlid R, Andersson G, Frostell CG, Jorbeck HJ, Ortqvist AB. 1996.
Respiratory tract colonization and infection in patients with chronic
tracheostomy. A one-year study in patients living at home.American journal of respiratory and critical care medicine.154(1):124-129.
21. Smith S, Rowbotham NJ, Regan KH. 2018. Inhaled anti‐pseudomonal
antibiotics for long‐term therapy in cystic fibrosis. Cochrane
Database of Systematic Reviews . (3).
22. Oermann CM, Retsch-Bogart GZ, Quittner AL, Gibson RL, McCoy KS,
Montgomery AB, Cooper PJ. 2010. An 18-month study of the safety and
efficacy of repeated courses of inhaled aztreonam lysine in cystic
fibrosis. Pediatr Pulmonol . 45(11):1121-1134.
23. Burns JL, Van Dalfsen JM, Shawar RM, Otto KL, Garber RL, Quan JM,
Montgomery AB, Albers GM, Ramsey BW, Smith AL. 1999. Effect of chronic
intermittent administration of inhaled tobramycin on respiratory
microbial flora in patients with cystic fibrosis. J Infect Dis.179(5):1190-1196.
24. Laska IF, Crichton ML, Shoemark A, Chalmers JD. 2019. The efficacy
and safety of inhaled antibiotics for the treatment of bronchiectasis in
adults: A systematic review and meta-analysis. The Lancet
Respiratory Medicine. 7(10):855-869.